Inogen Swaps CEO, Elevates COO Andy Reding as Kevin Smith Departs
INGN sits 35% above its 52-week low of $5.045.
Summary
Inogen's board named COO Andy Reding as President and CEO and put him on the board, replacing Kevin Smith. Reding only joined the company as COO in July 2026, so this is a rapid promotion of a newcomer rather than a long-tenured internal handoff. Board chair Elizabeth Mora framed the move bluntly: the company has an opportunity but "must do more to improve performance," and the board decided now was the right time for a change. Reding was central to the Rotech divestiture announced September 30, which the company expects to push it toward a leaner commercial model. The timing matters — the same release says Q3 2026 results come out today with a 5:00 p.m. ET call, so the new CEO inherits the numbers and the guidance discussion immediately.
At the time of this announcement, INGN was trading at $6.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $180.6M. The 52-week trading range was $5.05 to $8.14. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.